GC Cell Corporation (KOSDAQ:144510)

Market Cap	297.09B -7.8%
Revenue (ttm)	165.52B -5.1%
Net Income	-272.86B
EPS	-18,158.00
Shares Out	15.03M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,989
Average Volume	47,786
Open	20,100
Previous Close	20,250
Day's Range	19,550 - 20,600
52-Week Range	18,210 - 28,450
Beta	n/a
RSI	29.71
Earnings Date	May 22, 2026

About GC Cell

GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin, South Korea.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 144510

Financial Performance

In 2025, GC Cell's revenue was 165.52 billion, a decrease of -5.12% compared to the previous year's 174.45 billion. Losses were -272.86 billion, 269.2% more than in 2024.